You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

BAYER PHARMS Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for BAYER PHARMS, and what generic and branded alternatives to BAYER PHARMS drugs are available?

BAYER PHARMS has twenty-nine approved drugs.

Summary for BAYER PHARMS

US Patents:	0
Tradenames:	22
Ingredients:	21
NDAs:	29

Drugs and US Patents for BAYER PHARMS

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bayer Pharms	CORT-DOME	hydrocortisone	CREAM;TOPICAL	009585-003	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Bayer Pharms	MEZLIN	mezlocillin sodium monohydrate	INJECTABLE;INJECTION	062372-003	May 13, 1982		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Bayer Pharms	LITHANE	lithium carbonate	TABLET;ORAL	018833-001	Jul 18, 1985		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Bayer Pharms	NYSTAFORM	clioquinol; nystatin	OINTMENT;TOPICAL	050235-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Bayer Pharms	AZLIN	azlocillin sodium	INJECTABLE;INJECTION	050562-001	Sep 3, 1982		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Bayer Pharms	DELTA-DOME	prednisone	TABLET;ORAL	080293-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Bayer Pharms	MEZLIN	mezlocillin sodium monohydrate	INJECTABLE;INJECTION	062697-002	Jan 22, 1987		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for BAYER PHARMS

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bayer Pharms	NIMOTOP	nimodipine	CAPSULE;ORAL	018869-001	Dec 28, 1988	4,406,906	⤷ Subscribe
Bayer Pharms	BAYCOL	cerivastatin sodium	TABLET;ORAL	020740-004	Jun 26, 1997	5,006,530	⤷ Subscribe
Bayer Pharms	BAYCOL	cerivastatin sodium	TABLET;ORAL	020740-003	Jun 26, 1997	5,006,530	⤷ Subscribe
Bayer Pharms	ADALAT	nifedipine	CAPSULE;ORAL	019478-001	Nov 27, 1985	3,644,627	⤷ Subscribe
Bayer Pharms	MYCELEX-G	clotrimazole	TABLET;VAGINAL	019069-001	Apr 19, 1985	3,705,172	⤷ Subscribe
Bayer Pharms	CIPRO IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	ciprofloxacin	INJECTABLE;INJECTION	019858-001	Dec 26, 1990	4,957,922*PED	⤷ Subscribe
Bayer Pharms	BAYCOL	cerivastatin sodium	TABLET;ORAL	020740-005	May 24, 1999	5,177,080	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.